Access Statistics for Diego Useche

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 0 0 0 0 0 4 19
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 1 1 9 9
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 2 2
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 4 4
Empirical Economic Analysis of Orphan Drug Legislation Impact on Innovation 0 0 0 0 0 0 3 3
Empirical economic analysis of orphan drug legislation impact on innovation 0 0 0 0 0 0 7 7
Highly Skilled and Well Connected: Migrant inventors in Cross-Border M&As 0 0 0 0 0 0 11 11
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 1 10 40 0 3 37 54
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 0 0 1 2 19 21
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 1 1 15 2 8 30 56
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021 0 0 0 0 0 0 1 2
Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies 0 0 0 0 0 1 7 7
Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies 0 0 0 0 0 1 9 9
Total Working Papers 0 2 11 55 4 16 143 204


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 2 6 34 0 2 13 120
Patenting Behaviour and the Survival of Newly Listed European Software Firms 0 0 0 7 0 0 5 29
Total Journal Articles 0 2 6 41 0 2 18 149
1 registered items for which data could not be found


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 1 9 1 2 23 60
Total Chapters 0 0 1 9 1 2 23 60


Statistics updated 2020-09-04